BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Petrone L, Bondet V, Vanini V, Cuzzi G, Palmieri F, Palucci I, Delogu G, Ciccosanti F, Fimia GM, Blauenfeldt T, Ruhwald M, Duffy D, Goletti D. First description of agonist and antagonist IP-10 in urine of patients with active TB. Int J Infect Dis 2019;78:15-21. [PMID: 30201505 DOI: 10.1016/j.ijid.2018.09.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Alonzi T, Petruccioli E, Vanini V, Fimia GM, Goletti D. Optimization of the autophagy measurement in a human cell line and primary cells by flow cytometry. Eur J Histochem 2019;63. [PMID: 31243942 DOI: 10.4081/ejh.2019.3044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
2 Qiu X, Tang Y, Zou R, Zeng Y, Yue Y, Li W, Qu Y, Mu D. Diagnostic accuracy of interferon-gamma-induced protein 10 for differentiating active tuberculosis from latent tuberculosis: A meta-analysis. Sci Rep 2019;9:11408. [PMID: 31388072 DOI: 10.1038/s41598-019-47923-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
3 Rambaran S, Naidoo K, Lewis L, Hassan-Moosa R, Govender D, Samsunder N, Scriba TJ, Padayatchi N, Sivro A. Effect of Inflammatory Cytokines/Chemokines on Pulmonary Tuberculosis Culture Conversion and Disease Severity in HIV-Infected and -Uninfected Individuals From South Africa. Front Immunol 2021;12:641065. [PMID: 33868272 DOI: 10.3389/fimmu.2021.641065] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Hoel IM, Jørstad MD, Marijani M, Ruhwald M, Mustafa T, Dyrhol-Riise AM. IP-10 dried blood spots assay monitoring treatment efficacy in extrapulmonary tuberculosis in a low-resource setting. Sci Rep 2019;9:3871. [PMID: 30846768 DOI: 10.1038/s41598-019-40458-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
5 Eribo OA, Leqheka MS, Malherbe ST, McAnda S, Stanley K, van der Spuy GD, Walzl G, Chegou NN. Host urine immunological biomarkers as potential candidates for the diagnosis of tuberculosis. Int J Infect Dis 2020;99:473-81. [PMID: 32800854 DOI: 10.1016/j.ijid.2020.08.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
6 Huang Z, Qian J, Jin Q, Liu F, Zhang G, Gu H, Fu L, Wang Y, Zhang X, Yu Y, Sun J. Expression and Analyses of CXCL9/10/11 and CXCR3 in Ulcerative Cutaneous Tuberculosis. J Interferon Cytokine Res 2022;42:180-90. [PMID: 35438529 DOI: 10.1089/jir.2021.0163] [Reference Citation Analysis]
7 Palucci I, Battah B, Salustri A, De Maio F, Petrone L, Ciccosanti F, Sali M, Bondet V, Duffy D, Fimia GM, Goletti D, Delogu G. IP-10 contributes to the inhibition of mycobacterial growth in an ex vivo whole blood assay. Int J Med Microbiol 2019;309:299-306. [PMID: 31147175 DOI: 10.1016/j.ijmm.2019.05.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
8 Malik IA, Ramadori G. Interleukin-6-Production Is Responsible for Induction of Hepatic Synthesis of Several Chemokines as Acute-Phase Mediators in Two Animal Models: Possible Significance for Interpretation of Laboratory Changes in Severely Ill Patients. Biology (Basel) 2022;11:470. [PMID: 35336843 DOI: 10.3390/biology11030470] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Mertaniasih NM, Ananda IGYP, Soedarsono S, Kusumaningrum D. Diagnosis Based on Detection of CXCL10 in Urine as Biomarker for The Determining Diagnosis of Active Lung Tuberculosis. IJTID 2021;9:57. [DOI: 10.20473/ijtid.v9i1.22160] [Reference Citation Analysis]